Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Current Assets (2017 - 2025)

Dr Reddys Laboratories (RDY) has 8 years of Current Assets data on record, last reported at -$1.7 billion in Q1 2024.

  • For Q1 2024, Current Assets fell 2080.14% year-over-year to -$1.7 billion; the TTM value through Mar 2023 reached $84.8 million, down 15.74%, while the annual FY2024 figure was -$1.7 billion, 2038.74% down from the prior year.
  • Current Assets reached -$1.7 billion in Q1 2024 per RDY's latest filing, down from $84.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $120.4 million in Q1 2021 and bottomed at -$1.7 billion in Q1 2024.
  • Average Current Assets over 5 years is -$255.6 million, with a median of $95.6 million recorded in 2020.
  • Peak YoY movement for Current Assets: grew 25.94% in 2021, then tumbled 2080.14% in 2024.
  • A 5-year view of Current Assets shows it stood at $95.6 million in 2020, then increased by 25.94% to $120.4 million in 2021, then dropped by 16.39% to $100.7 million in 2022, then decreased by 15.74% to $84.8 million in 2023, then crashed by 2080.14% to -$1.7 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Current Assets were -$1.7 billion in Q1 2024, $84.8 million in Q1 2023, and $100.7 million in Q1 2022.